| GO:0010911 | regulation of isomerase activity | 100.0% (2/2) | 13.25 | 0.0 | 0.0 |
| GO:0010912 | positive regulation of isomerase activity | 100.0% (2/2) | 13.25 | 0.0 | 0.0 |
| GO:0045433 | male courtship behavior, veined wing generated song production | 100.0% (2/2) | 13.25 | 0.0 | 0.0 |
| GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 100.0% (2/2) | 13.25 | 0.0 | 0.0 |
| GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 100.0% (2/2) | 13.25 | 0.0 | 0.0 |
| GO:0072487 | MSL complex | 100.0% (2/2) | 12.93 | 0.0 | 0.0 |
| GO:0106222 | lncRNA binding | 100.0% (2/2) | 12.93 | 0.0 | 0.0 |
| GO:1903608 | protein localization to cytoplasmic stress granule | 100.0% (2/2) | 12.93 | 0.0 | 0.0 |
| GO:0070937 | CRD-mediated mRNA stability complex | 100.0% (2/2) | 13.67 | 0.0 | 1e-06 |
| GO:1905696 | regulation of polysome binding | 100.0% (2/2) | 13.67 | 0.0 | 1e-06 |
| GO:1905698 | positive regulation of polysome binding | 100.0% (2/2) | 13.67 | 0.0 | 1e-06 |
| GO:0039695 | DNA-templated viral transcription | 100.0% (2/2) | 12.67 | 0.0 | 1e-06 |
| GO:0071360 | cellular response to exogenous dsRNA | 100.0% (2/2) | 12.67 | 0.0 | 1e-06 |
| GO:0001069 | regulatory region RNA binding | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0008049 | male courtship behavior | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0032755 | positive regulation of interleukin-6 production | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0051890 | regulation of cardioblast differentiation | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0051891 | positive regulation of cardioblast differentiation | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:1902064 | obsolete regulation of transcription from RNA polymerase II promoter involved in spermatogenesis | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0033679 | 3'-5' DNA/RNA helicase activity | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0071359 | cellular response to dsRNA | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:1990518 | single-stranded 3'-5' DNA helicase activity | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0060179 | male mating behavior | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:0070883 | pre-miRNA binding | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:0090669 | telomerase RNA stabilization | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:1904582 | positive regulation of intracellular mRNA localization | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:0002730 | regulation of dendritic cell cytokine production | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0002732 | positive regulation of dendritic cell cytokine production | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0002733 | regulation of myeloid dendritic cell cytokine production | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0002735 | positive regulation of myeloid dendritic cell cytokine production | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0002888 | positive regulation of myeloid leukocyte mediated immunity | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0007617 | mating behavior | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0048675 | axon extension | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:1905207 | regulation of cardiocyte differentiation | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:1905209 | positive regulation of cardiocyte differentiation | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0000805 | X chromosome | 100.0% (2/2) | 11.45 | 0.0 | 1e-06 |
| GO:0034458 | 3'-5' RNA helicase activity | 100.0% (2/2) | 11.45 | 0.0 | 1e-06 |
| GO:0060760 | positive regulation of response to cytokine stimulus | 100.0% (2/2) | 11.45 | 0.0 | 1e-06 |
| GO:0061003 | positive regulation of dendritic spine morphogenesis | 100.0% (2/2) | 11.45 | 0.0 | 1e-06 |
| GO:0032675 | regulation of interleukin-6 production | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0007619 | courtship behavior | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0032760 | positive regulation of tumor necrosis factor production | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0070578 | RISC-loading complex | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0097165 | nuclear stress granule | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0047429 | nucleoside triphosphate diphosphatase activity | 100.0% (2/2) | 11.25 | 0.0 | 1e-06 |
| GO:1903842 | response to arsenite ion | 100.0% (2/2) | 11.25 | 0.0 | 1e-06 |
| GO:1903843 | cellular response to arsenite ion | 100.0% (2/2) | 11.25 | 0.0 | 1e-06 |
| GO:0019083 | viral transcription | 100.0% (2/2) | 11.17 | 0.0 | 1e-06 |
| GO:0032647 | regulation of interferon-alpha production | 100.0% (2/2) | 11.17 | 0.0 | 1e-06 |
| GO:0032727 | positive regulation of interferon-alpha production | 100.0% (2/2) | 11.17 | 0.0 | 1e-06 |
| GO:0043330 | response to exogenous dsRNA | 100.0% (2/2) | 11.17 | 0.0 | 1e-06 |
| GO:0043331 | response to dsRNA | 100.0% (2/2) | 11.08 | 0.0 | 1e-06 |
| GO:0002720 | positive regulation of cytokine production involved in immune response | 100.0% (2/2) | 11.01 | 0.0 | 2e-06 |
| GO:0002718 | regulation of cytokine production involved in immune response | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0019098 | reproductive behavior | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0032680 | regulation of tumor necrosis factor production | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0035197 | siRNA binding | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0002886 | regulation of myeloid leukocyte mediated immunity | 100.0% (2/2) | 10.86 | 0.0 | 2e-06 |
| GO:0003688 | DNA replication origin binding | 100.0% (2/2) | 10.86 | 0.0 | 2e-06 |
| GO:1904580 | regulation of intracellular mRNA localization | 100.0% (2/2) | 10.86 | 0.0 | 2e-06 |
| GO:0033677 | DNA/RNA helicase activity | 100.0% (2/2) | 10.8 | 0.0 | 2e-06 |
| GO:0061001 | regulation of dendritic spine morphogenesis | 100.0% (2/2) | 10.8 | 0.0 | 2e-06 |
| GO:0032728 | positive regulation of interferon-beta production | 100.0% (2/2) | 10.73 | 0.0 | 2e-06 |
| GO:0044806 | G-quadruplex DNA unwinding | 100.0% (2/2) | 10.67 | 0.0 | 2e-06 |
| GO:0008494 | translation activator activity | 100.0% (2/2) | 10.61 | 0.0 | 2e-06 |
| GO:0071243 | cellular response to arsenic-containing substance | 100.0% (2/2) | 10.61 | 0.0 | 2e-06 |
| GO:2000738 | positive regulation of stem cell differentiation | 100.0% (2/2) | 10.61 | 0.0 | 2e-06 |
| GO:0031453 | positive regulation of heterochromatin formation | 100.0% (2/2) | 10.55 | 0.0 | 2e-06 |
| GO:0120263 | positive regulation of heterochromatin organization | 100.0% (2/2) | 10.55 | 0.0 | 2e-06 |
| GO:0032648 | regulation of interferon-beta production | 100.0% (2/2) | 10.5 | 0.0 | 2e-06 |
| GO:0060999 | positive regulation of dendritic spine development | 100.0% (2/2) | 10.5 | 0.0 | 2e-06 |
| GO:1902555 | endoribonuclease complex | 100.0% (2/2) | 10.4 | 1e-06 | 3e-06 |
| GO:1990138 | neuron projection extension | 100.0% (2/2) | 10.4 | 1e-06 | 3e-06 |
| GO:2000765 | regulation of cytoplasmic translation | 100.0% (2/2) | 10.4 | 1e-06 | 3e-06 |
| GO:0050775 | positive regulation of dendrite morphogenesis | 100.0% (2/2) | 10.35 | 1e-06 | 3e-06 |
| GO:1905348 | endonuclease complex | 100.0% (2/2) | 10.35 | 1e-06 | 3e-06 |
| GO:0043138 | 3'-5' DNA helicase activity | 100.0% (2/2) | 10.3 | 1e-06 | 3e-06 |
| GO:0001731 | formation of translation preinitiation complex | 100.0% (2/2) | 10.25 | 1e-06 | 3e-06 |
| GO:0051880 | G-quadruplex DNA binding | 100.0% (2/2) | 10.25 | 1e-06 | 3e-06 |
| GO:1905269 | positive regulation of chromatin organization | 100.0% (2/2) | 10.25 | 1e-06 | 3e-06 |
| GO:0035613 | RNA stem-loop binding | 100.0% (2/2) | 10.21 | 1e-06 | 3e-06 |
| GO:0000803 | sex chromosome | 100.0% (2/2) | 10.04 | 1e-06 | 4e-06 |
| GO:0043024 | ribosomal small subunit binding | 100.0% (2/2) | 10.04 | 1e-06 | 4e-06 |
| GO:0016282 | eukaryotic 43S preinitiation complex | 100.0% (2/2) | 10.01 | 1e-06 | 4e-06 |
| GO:1902562 | H4 histone acetyltransferase complex | 100.0% (2/2) | 9.97 | 1e-06 | 4e-06 |
| GO:0007417 | central nervous system development | 100.0% (2/2) | 9.93 | 1e-06 | 5e-06 |
| GO:0032781 | positive regulation of ATP-dependent activity | 100.0% (2/2) | 9.93 | 1e-06 | 5e-06 |
| GO:0032481 | positive regulation of type I interferon production | 100.0% (2/2) | 9.9 | 1e-06 | 5e-06 |
| GO:0035925 | mRNA 3'-UTR AU-rich region binding | 100.0% (2/2) | 9.9 | 1e-06 | 5e-06 |
| GO:0060998 | regulation of dendritic spine development | 100.0% (2/2) | 9.86 | 1e-06 | 5e-06 |
| GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 100.0% (2/2) | 9.83 | 1e-06 | 5e-06 |
| GO:0007549 | dosage compensation | 100.0% (2/2) | 9.8 | 1e-06 | 5e-06 |
| GO:0017116 | single-stranded DNA helicase activity | 100.0% (2/2) | 9.8 | 1e-06 | 5e-06 |
| GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 100.0% (2/2) | 9.8 | 1e-06 | 5e-06 |
| GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 100.0% (2/2) | 9.8 | 1e-06 | 5e-06 |
| GO:0001503 | ossification | 100.0% (2/2) | 9.76 | 1e-06 | 5e-06 |
| GO:0060759 | regulation of response to cytokine stimulus | 100.0% (2/2) | 9.76 | 1e-06 | 5e-06 |
| GO:2000144 | positive regulation of DNA-templated transcription initiation | 100.0% (2/2) | 9.73 | 1e-06 | 5e-06 |
| GO:0048814 | regulation of dendrite morphogenesis | 100.0% (2/2) | 9.67 | 1e-06 | 6e-06 |
| GO:0070993 | translation preinitiation complex | 100.0% (2/2) | 9.64 | 2e-06 | 6e-06 |
| GO:0099175 | regulation of postsynapse organization | 100.0% (2/2) | 9.64 | 2e-06 | 6e-06 |
| GO:0060260 | regulation of transcription initiation by RNA polymerase II | 100.0% (2/2) | 9.58 | 2e-06 | 6e-06 |
| GO:0031445 | regulation of heterochromatin formation | 100.0% (2/2) | 9.5 | 2e-06 | 7e-06 |
| GO:0032479 | regulation of type I interferon production | 100.0% (2/2) | 9.5 | 2e-06 | 7e-06 |
| GO:0120261 | regulation of heterochromatin organization | 100.0% (2/2) | 9.5 | 2e-06 | 7e-06 |
| GO:0002705 | positive regulation of leukocyte mediated immunity | 100.0% (2/2) | 9.47 | 2e-06 | 7e-06 |
| GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 100.0% (2/2) | 9.47 | 2e-06 | 7e-06 |
| GO:0061980 | regulatory RNA binding | 100.0% (2/2) | 9.47 | 2e-06 | 7e-06 |
| GO:0045739 | positive regulation of DNA repair | 100.0% (2/2) | 9.42 | 2e-06 | 8e-06 |
| GO:0043204 | perikaryon | 100.0% (2/2) | 9.4 | 2e-06 | 8e-06 |
| GO:2000142 | regulation of DNA-templated transcription initiation | 100.0% (2/2) | 9.37 | 2e-06 | 8e-06 |
| GO:0050773 | regulation of dendrite development | 100.0% (2/2) | 9.28 | 3e-06 | 9e-06 |
| GO:0002703 | regulation of leukocyte mediated immunity | 100.0% (2/2) | 9.23 | 3e-06 | 9e-06 |
| GO:2001022 | positive regulation of response to DNA damage stimulus | 100.0% (2/2) | 9.17 | 3e-06 | 1e-05 |
| GO:0002702 | positive regulation of production of molecular mediator of immune response | 100.0% (2/2) | 9.15 | 3e-06 | 1.1e-05 |
| GO:2000736 | regulation of stem cell differentiation | 100.0% (2/2) | 9.13 | 3e-06 | 1.1e-05 |
| GO:0042255 | ribosome assembly | 100.0% (2/2) | 9.1 | 3e-06 | 1.1e-05 |
| GO:0003725 | double-stranded RNA binding | 100.0% (2/2) | 9.08 | 3e-06 | 1.1e-05 |
| GO:0002700 | regulation of production of molecular mediator of immune response | 100.0% (2/2) | 8.97 | 4e-06 | 1.3e-05 |
| GO:0070063 | RNA polymerase binding | 100.0% (2/2) | 8.95 | 4e-06 | 1.3e-05 |
| GO:0043462 | regulation of ATP-dependent activity | 100.0% (2/2) | 8.93 | 4e-06 | 1.3e-05 |
| GO:0005700 | polytene chromosome | 100.0% (2/2) | 8.9 | 4e-06 | 1.4e-05 |
| GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 100.0% (2/2) | 8.88 | 4e-06 | 1.4e-05 |
| GO:0010976 | positive regulation of neuron projection development | 100.0% (2/2) | 8.86 | 5e-06 | 1.5e-05 |
| GO:0042826 | histone deacetylase binding | 100.0% (2/2) | 8.7 | 6e-06 | 1.8e-05 |
| GO:0043489 | RNA stabilization | 100.0% (2/2) | 8.68 | 6e-06 | 1.8e-05 |
| GO:1902275 | regulation of chromatin organization | 100.0% (2/2) | 8.68 | 6e-06 | 1.8e-05 |
| GO:0046685 | response to arsenic-containing substance | 100.0% (2/2) | 8.67 | 6e-06 | 1.8e-05 |
| GO:0032508 | DNA duplex unwinding | 100.0% (2/2) | 8.57 | 7e-06 | 2.1e-05 |
| GO:1902369 | negative regulation of RNA catabolic process | 100.0% (2/2) | 8.54 | 7e-06 | 2.2e-05 |
| GO:0000123 | histone acetyltransferase complex | 100.0% (2/2) | 8.51 | 7e-06 | 2.2e-05 |
| GO:2001252 | positive regulation of chromosome organization | 100.0% (2/2) | 8.46 | 8e-06 | 2.4e-05 |
| GO:0002699 | positive regulation of immune effector process | 100.0% (2/2) | 8.42 | 8e-06 | 2.5e-05 |
| GO:0001819 | positive regulation of cytokine production | 100.0% (2/2) | 8.37 | 9e-06 | 2.6e-05 |
| GO:0032392 | DNA geometric change | 100.0% (2/2) | 8.37 | 9e-06 | 2.6e-05 |
| GO:0031248 | protein acetyltransferase complex | 100.0% (2/2) | 8.35 | 9e-06 | 2.7e-05 |
| GO:1902493 | acetyltransferase complex | 100.0% (2/2) | 8.35 | 9e-06 | 2.7e-05 |
| GO:0031490 | chromatin DNA binding | 100.0% (2/2) | 8.34 | 1e-05 | 2.7e-05 |
| GO:0003730 | mRNA 3'-UTR binding | 100.0% (2/2) | 8.31 | 1e-05 | 2.8e-05 |
| GO:0015629 | actin cytoskeleton | 100.0% (2/2) | 8.31 | 1e-05 | 2.8e-05 |
| GO:0050769 | positive regulation of neurogenesis | 100.0% (2/2) | 8.3 | 1e-05 | 2.8e-05 |
| GO:0002697 | regulation of immune effector process | 100.0% (2/2) | 8.28 | 1e-05 | 2.9e-05 |
| GO:0050807 | regulation of synapse organization | 100.0% (2/2) | 8.27 | 1e-05 | 2.9e-05 |
| GO:0003724 | RNA helicase activity | 100.0% (2/2) | 8.23 | 1.1e-05 | 3e-05 |
| GO:0071103 | DNA conformation change | 100.0% (2/2) | 8.18 | 1.2e-05 | 3.2e-05 |
| GO:0003678 | DNA helicase activity | 100.0% (2/2) | 8.14 | 1.3e-05 | 3.4e-05 |
| GO:0051962 | positive regulation of nervous system development | 100.0% (2/2) | 8.14 | 1.3e-05 | 3.4e-05 |
| GO:0022627 | cytosolic small ribosomal subunit | 100.0% (2/2) | 8.13 | 1.3e-05 | 3.4e-05 |
| GO:0051099 | positive regulation of binding | 100.0% (2/2) | 8.13 | 1.3e-05 | 3.4e-05 |
| GO:0000228 | nuclear chromosome | 100.0% (2/2) | 8.08 | 1.3e-05 | 3.5e-05 |
| GO:0008186 | ATP-dependent activity, acting on RNA | 100.0% (2/2) | 8.08 | 1.3e-05 | 3.5e-05 |
| GO:0045995 | regulation of embryonic development | 100.0% (2/2) | 7.99 | 1.5e-05 | 4e-05 |
| GO:0006282 | regulation of DNA repair | 100.0% (2/2) | 7.94 | 1.6e-05 | 4.3e-05 |
| GO:0010494 | cytoplasmic stress granule | 100.0% (2/2) | 7.91 | 1.7e-05 | 4.4e-05 |
| GO:0015935 | small ribosomal subunit | 100.0% (2/2) | 7.91 | 1.7e-05 | 4.4e-05 |
| GO:0008340 | determination of adult lifespan | 100.0% (2/2) | 7.91 | 1.7e-05 | 4.4e-05 |
| GO:0010720 | positive regulation of cell development | 100.0% (2/2) | 7.75 | 2.2e-05 | 5.5e-05 |
| GO:0030424 | axon | 100.0% (2/2) | 7.74 | 2.2e-05 | 5.5e-05 |
| GO:0001817 | regulation of cytokine production | 100.0% (2/2) | 7.72 | 2.2e-05 | 5.6e-05 |
| GO:0050767 | regulation of neurogenesis | 100.0% (2/2) | 7.71 | 2.3e-05 | 5.6e-05 |
| GO:0031346 | positive regulation of cell projection organization | 100.0% (2/2) | 7.66 | 2.4e-05 | 6e-05 |
| GO:0030425 | dendrite | 100.0% (2/2) | 7.58 | 2.7e-05 | 6.6e-05 |
| GO:0043488 | regulation of mRNA stability | 100.0% (2/2) | 7.58 | 2.7e-05 | 6.6e-05 |
| GO:0090079 | translation regulator activity, nucleic acid binding | 100.0% (2/2) | 7.59 | 2.7e-05 | 6.6e-05 |
| GO:1903313 | positive regulation of mRNA metabolic process | 100.0% (2/2) | 7.51 | 3e-05 | 7.3e-05 |
| GO:0051960 | regulation of nervous system development | 100.0% (2/2) | 7.49 | 3.1e-05 | 7.4e-05 |
| GO:0008094 | ATP-dependent activity, acting on DNA | 100.0% (2/2) | 7.45 | 3.2e-05 | 7.7e-05 |
| GO:0051054 | positive regulation of DNA metabolic process | 100.0% (2/2) | 7.45 | 3.2e-05 | 7.7e-05 |
| GO:0043487 | regulation of RNA stability | 100.0% (2/2) | 7.43 | 3.3e-05 | 7.8e-05 |
| GO:0016032 | viral process | 100.0% (2/2) | 7.42 | 3.4e-05 | 7.9e-05 |
| GO:0043021 | ribonucleoprotein complex binding | 100.0% (2/2) | 7.4 | 3.5e-05 | 8.1e-05 |
| GO:0042788 | polysomal ribosome | 100.0% (2/2) | 7.4 | 3.5e-05 | 8.1e-05 |
| GO:0050684 | regulation of mRNA processing | 100.0% (2/2) | 7.38 | 3.6e-05 | 8.2e-05 |
| GO:0061013 | regulation of mRNA catabolic process | 100.0% (2/2) | 7.38 | 3.6e-05 | 8.2e-05 |
| GO:0010975 | regulation of neuron projection development | 100.0% (2/2) | 7.36 | 3.7e-05 | 8.4e-05 |
| GO:0031330 | negative regulation of cellular catabolic process | 100.0% (2/2) | 7.31 | 3.9e-05 | 8.9e-05 |
| GO:2001020 | regulation of response to DNA damage stimulus | 100.0% (2/2) | 7.26 | 4.2e-05 | 9.5e-05 |
| GO:0040029 | epigenetic regulation of gene expression | 100.0% (2/2) | 7.22 | 4.5e-05 | 0.0001 |
| GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 100.0% (2/2) | 7.19 | 4.7e-05 | 0.000104 |
| GO:0060284 | regulation of cell development | 100.0% (2/2) | 7.14 | 5e-05 | 0.000111 |
| GO:0010769 | regulation of cell morphogenesis involved in differentiation | 100.0% (2/2) | 7.13 | 5.1e-05 | 0.000112 |
| GO:0045182 | translation regulator activity | 100.0% (2/2) | 7.12 | 5.1e-05 | 0.000113 |
| GO:0004386 | helicase activity | 100.0% (2/2) | 7.1 | 5.3e-05 | 0.000115 |
| GO:0044089 | positive regulation of cellular component biogenesis | 100.0% (2/2) | 7.07 | 5.5e-05 | 0.00012 |
| GO:0033044 | regulation of chromosome organization | 100.0% (2/2) | 7.04 | 5.8e-05 | 0.000125 |
| GO:0051098 | regulation of binding | 100.0% (2/2) | 6.99 | 6.2e-05 | 0.000133 |
| GO:0005813 | centrosome | 100.0% (2/2) | 6.98 | 6.2e-05 | 0.000133 |
| GO:0120035 | regulation of plasma membrane bounded cell projection organization | 100.0% (2/2) | 6.96 | 6.4e-05 | 0.000136 |
| GO:0031344 | regulation of cell projection organization | 100.0% (2/2) | 6.91 | 6.9e-05 | 0.000145 |
| GO:0009895 | negative regulation of catabolic process | 100.0% (2/2) | 6.9 | 7e-05 | 0.000146 |
| GO:0022618 | ribonucleoprotein complex assembly | 100.0% (2/2) | 6.87 | 7.3e-05 | 0.000153 |
| GO:0140694 | non-membrane-bounded organelle assembly | 100.0% (2/2) | 6.82 | 7.9e-05 | 0.000163 |
| GO:0071407 | cellular response to organic cyclic compound | 100.0% (2/2) | 6.79 | 8.1e-05 | 0.000168 |
| GO:0071826 | ribonucleoprotein complex subunit organization | 100.0% (2/2) | 6.78 | 8.2e-05 | 0.000169 |
| GO:0140097 | catalytic activity, acting on DNA | 100.0% (2/2) | 6.77 | 8.4e-05 | 0.000171 |
| GO:0140297 | DNA-binding transcription factor binding | 100.0% (2/2) | 6.73 | 8.9e-05 | 0.000181 |
| GO:0007610 | behavior | 100.0% (2/2) | 6.7 | 9.2e-05 | 0.000186 |
| GO:0010638 | positive regulation of organelle organization | 100.0% (2/2) | 6.68 | 9.4e-05 | 0.00019 |
| GO:0044391 | ribosomal subunit | 100.0% (2/2) | 6.63 | 0.000102 | 0.000204 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 100.0% (2/2) | 6.63 | 0.000102 | 0.000204 |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.62 | 0.000103 | 0.000205 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 100.0% (2/2) | 6.61 | 0.000104 | 0.000205 |
| GO:0035770 | ribonucleoprotein granule | 100.0% (2/2) | 6.59 | 0.000107 | 0.000211 |
| GO:1903311 | regulation of mRNA metabolic process | 100.0% (2/2) | 6.58 | 0.000109 | 0.000214 |
| GO:0000287 | magnesium ion binding | 100.0% (2/2) | 6.56 | 0.000111 | 0.000217 |
| GO:0045597 | positive regulation of cell differentiation | 100.0% (2/2) | 6.55 | 0.000114 | 0.000221 |
| GO:1902533 | positive regulation of intracellular signal transduction | 100.0% (2/2) | 6.48 | 0.000125 | 0.000242 |
| GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.41 | 0.000139 | 0.000266 |
| GO:0005815 | microtubule organizing center | 100.0% (2/2) | 6.4 | 0.000141 | 0.000269 |
| GO:0005840 | ribosome | 100.0% (2/2) | 6.39 | 0.000142 | 0.000271 |
| GO:0003712 | transcription coregulator activity | 100.0% (2/2) | 6.38 | 0.000144 | 0.000272 |
| GO:1901699 | cellular response to nitrogen compound | 100.0% (2/2) | 6.37 | 0.000146 | 0.000275 |
| GO:0000785 | chromatin | 100.0% (2/2) | 6.33 | 0.000154 | 0.000289 |
| GO:0043085 | positive regulation of catalytic activity | 100.0% (2/2) | 6.29 | 0.000164 | 0.000306 |
| GO:0016462 | pyrophosphatase activity | 100.0% (2/2) | 6.28 | 0.000166 | 0.000307 |
| GO:0051276 | chromosome organization | 100.0% (2/2) | 6.28 | 0.000166 | 0.000307 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 100.0% (2/2) | 6.26 | 0.000171 | 0.000314 |
| GO:0009615 | response to virus | 100.0% (2/2) | 6.25 | 0.000173 | 0.000316 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 100.0% (2/2) | 6.2 | 0.000184 | 0.000335 |
| GO:0000987 | cis-regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.2 | 0.000186 | 0.000337 |
| GO:0070925 | organelle assembly | 100.0% (2/2) | 6.19 | 0.000187 | 0.000338 |
| GO:0043005 | neuron projection | 100.0% (2/2) | 6.18 | 0.000191 | 0.000343 |
| GO:0051052 | regulation of DNA metabolic process | 100.0% (2/2) | 6.16 | 0.000196 | 0.000352 |
| GO:0008134 | transcription factor binding | 100.0% (2/2) | 6.13 | 0.000203 | 0.000363 |
| GO:0022604 | regulation of cell morphogenesis | 100.0% (2/2) | 6.12 | 0.000207 | 0.000368 |
| GO:0005694 | chromosome | 100.0% (2/2) | 6.1 | 0.000211 | 0.000373 |
| GO:0005856 | cytoskeleton | 100.0% (2/2) | 6.05 | 0.000226 | 0.000398 |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 100.0% (2/2) | 6.02 | 0.000238 | 0.000417 |
| GO:0006417 | regulation of translation | 100.0% (2/2) | 5.96 | 0.000257 | 0.000449 |
| GO:0003682 | chromatin binding | 100.0% (2/2) | 5.9 | 0.00028 | 0.000488 |
| GO:0034248 | regulation of cellular amide metabolic process | 100.0% (2/2) | 5.87 | 0.000293 | 0.000508 |
| GO:0016604 | nuclear body | 100.0% (2/2) | 5.85 | 0.0003 | 0.000518 |
| GO:0060341 | regulation of cellular localization | 100.0% (2/2) | 5.82 | 0.000312 | 0.000536 |
| GO:0140098 | catalytic activity, acting on RNA | 100.0% (2/2) | 5.8 | 0.00032 | 0.000548 |
| GO:0051130 | positive regulation of cellular component organization | 100.0% (2/2) | 5.73 | 0.000354 | 0.000603 |
| GO:0080135 | regulation of cellular response to stress | 100.0% (2/2) | 5.7 | 0.000368 | 0.000624 |
| GO:0044087 | regulation of cellular component biogenesis | 100.0% (2/2) | 5.68 | 0.000383 | 0.000646 |
| GO:0033365 | protein localization to organelle | 100.0% (2/2) | 5.64 | 0.000403 | 0.000677 |
| GO:0031329 | regulation of cellular catabolic process | 100.0% (2/2) | 5.62 | 0.000413 | 0.000692 |
| GO:0044093 | positive regulation of molecular function | 100.0% (2/2) | 5.57 | 0.000442 | 0.000737 |
| GO:0010608 | post-transcriptional regulation of gene expression | 100.0% (2/2) | 5.56 | 0.000447 | 0.000743 |
| GO:2000112 | regulation of cellular macromolecule biosynthetic process | 100.0% (2/2) | 5.54 | 0.000459 | 0.00076 |
| GO:0002684 | positive regulation of immune system process | 100.0% (2/2) | 5.51 | 0.000478 | 0.000787 |
| GO:0140657 | ATP-dependent activity | 100.0% (2/2) | 5.51 | 0.000481 | 0.00079 |
| GO:0048588 | developmental cell growth | 100.0% (2/2) | 5.43 | 0.000534 | 0.000873 |
| GO:0045595 | regulation of cell differentiation | 100.0% (2/2) | 5.42 | 0.000547 | 0.000891 |
| GO:0010628 | positive regulation of gene expression | 100.0% (2/2) | 5.41 | 0.000553 | 0.000897 |
| GO:0033043 | regulation of organelle organization | 100.0% (2/2) | 5.39 | 0.000564 | 0.000911 |
| GO:0009894 | regulation of catabolic process | 100.0% (2/2) | 5.27 | 0.000675 | 0.001073 |
| GO:1902531 | regulation of intracellular signal transduction | 100.0% (2/2) | 5.27 | 0.000675 | 0.001073 |
| GO:0140535 | intracellular protein-containing complex | 100.0% (2/2) | 5.27 | 0.000674 | 0.001079 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 100.0% (2/2) | 5.27 | 0.000672 | 0.001082 |
| GO:0099080 | supramolecular complex | 100.0% (2/2) | 5.25 | 0.00069 | 0.001092 |
| GO:0044877 | protein-containing complex binding | 100.0% (2/2) | 5.24 | 0.000703 | 0.001109 |
| GO:0009967 | positive regulation of signal transduction | 100.0% (2/2) | 5.19 | 0.000747 | 0.001174 |
| GO:0051240 | positive regulation of multicellular organismal process | 100.0% (2/2) | 5.19 | 0.000751 | 0.001176 |
| GO:1990234 | transferase complex | 100.0% (2/2) | 5.17 | 0.000767 | 0.001196 |
| GO:1990904 | ribonucleoprotein complex | 100.0% (2/2) | 5.13 | 0.000814 | 0.001265 |
| GO:0048731 | system development | 100.0% (2/2) | 5.13 | 0.00082 | 0.001269 |
| GO:0022603 | regulation of anatomical structure morphogenesis | 100.0% (2/2) | 5.12 | 0.000825 | 0.001271 |
| GO:0023056 | positive regulation of signaling | 100.0% (2/2) | 5.08 | 0.000872 | 0.00134 |
| GO:0010647 | positive regulation of cell communication | 100.0% (2/2) | 5.06 | 0.000894 | 0.001367 |
| GO:0120025 | plasma membrane bounded cell projection | 100.0% (2/2) | 4.99 | 0.000985 | 0.001501 |
| GO:0050790 | regulation of catalytic activity | 100.0% (2/2) | 4.92 | 0.001093 | 0.001661 |
| GO:0042995 | cell projection | 100.0% (2/2) | 4.87 | 0.001164 | 0.001761 |
| GO:0065003 | protein-containing complex assembly | 100.0% (2/2) | 4.84 | 0.001211 | 0.001826 |
| GO:0051094 | positive regulation of developmental process | 100.0% (2/2) | 4.81 | 0.001264 | 0.001898 |
| GO:1901701 | cellular response to oxygen-containing compound | 100.0% (2/2) | 4.81 | 0.001271 | 0.001902 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 100.0% (2/2) | 4.79 | 0.001298 | 0.001936 |
| GO:0051253 | negative regulation of RNA metabolic process | 100.0% (2/2) | 4.77 | 0.001341 | 0.001992 |
| GO:0060560 | developmental growth involved in morphogenesis | 100.0% (2/2) | 4.74 | 0.001398 | 0.002069 |
| GO:0140513 | nuclear protein-containing complex | 100.0% (2/2) | 4.72 | 0.001446 | 0.002133 |
| GO:0043933 | protein-containing complex organization | 100.0% (2/2) | 4.64 | 0.0016 | 0.002351 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.64 | 0.001614 | 0.002363 |
| GO:0071310 | cellular response to organic substance | 100.0% (2/2) | 4.62 | 0.001647 | 0.002403 |
| GO:0002682 | regulation of immune system process | 100.0% (2/2) | 4.55 | 0.001826 | 0.002627 |
| GO:0003729 | mRNA binding | 100.0% (2/2) | 4.55 | 0.001824 | 0.002633 |
| GO:0008104 | protein localization | 100.0% (2/2) | 4.55 | 0.00182 | 0.002636 |
| GO:0016049 | cell growth | 100.0% (2/2) | 4.55 | 0.00182 | 0.002636 |
| GO:0048589 | developmental growth | 100.0% (2/2) | 4.44 | 0.002115 | 0.003031 |
| GO:0045893 | positive regulation of DNA-templated transcription | 100.0% (2/2) | 4.41 | 0.002224 | 0.003177 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 100.0% (2/2) | 4.39 | 0.00227 | 0.003209 |
| GO:0070727 | cellular macromolecule localization | 100.0% (2/2) | 4.4 | 0.002256 | 0.00321 |
| GO:1903508 | positive regulation of nucleic acid-templated transcription | 100.0% (2/2) | 4.39 | 0.002266 | 0.003213 |
| GO:0032879 | regulation of localization | 100.0% (2/2) | 4.38 | 0.002297 | 0.003235 |
| GO:1902494 | catalytic complex | 100.0% (2/2) | 4.36 | 0.002364 | 0.003318 |
| GO:1901698 | response to nitrogen compound | 100.0% (2/2) | 4.36 | 0.002382 | 0.003331 |
| GO:0000976 | transcription cis-regulatory region binding | 100.0% (2/2) | 4.34 | 0.002452 | 0.003418 |
| GO:0001067 | transcription regulatory region nucleic acid binding | 100.0% (2/2) | 4.33 | 0.00247 | 0.003431 |
| GO:1990837 | sequence-specific double-stranded DNA binding | 100.0% (2/2) | 4.3 | 0.002567 | 0.003554 |
| GO:0005524 | ATP binding | 100.0% (2/2) | 4.29 | 0.002614 | 0.003607 |
| GO:0005739 | mitochondrion | 100.0% (2/2) | 4.28 | 0.002633 | 0.003608 |
| GO:0014070 | response to organic cyclic compound | 100.0% (2/2) | 4.28 | 0.002633 | 0.003608 |
| GO:0065009 | regulation of molecular function | 100.0% (2/2) | 4.27 | 0.002688 | 0.003671 |
| GO:0051254 | positive regulation of RNA metabolic process | 100.0% (2/2) | 4.24 | 0.002784 | 0.00379 |
| GO:0033036 | macromolecule localization | 100.0% (2/2) | 4.24 | 0.002806 | 0.003807 |
| GO:0040007 | growth | 100.0% (2/2) | 4.21 | 0.002907 | 0.003931 |
| GO:0140110 | transcription regulator activity | 100.0% (2/2) | 4.21 | 0.002929 | 0.003948 |
| GO:0019899 | enzyme binding | 100.0% (2/2) | 4.19 | 0.003004 | 0.004036 |
| GO:2000026 | regulation of multicellular organismal development | 100.0% (2/2) | 4.18 | 0.003027 | 0.004039 |
| GO:0032559 | adenyl ribonucleotide binding | 100.0% (2/2) | 4.18 | 0.003038 | 0.004041 |
| GO:0003690 | double-stranded DNA binding | 100.0% (2/2) | 4.19 | 0.003018 | 0.004041 |
| GO:0051246 | regulation of protein metabolic process | 100.0% (2/2) | 4.17 | 0.003072 | 0.004046 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.18 | 0.003058 | 0.004054 |
| GO:0030554 | adenyl nucleotide binding | 100.0% (2/2) | 4.17 | 0.003069 | 0.004056 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.13 | 0.003259 | 0.004279 |
| GO:0051128 | regulation of cellular component organization | 100.0% (2/2) | 4.11 | 0.003365 | 0.004404 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 100.0% (2/2) | 4.09 | 0.003458 | 0.004511 |
| GO:0051641 | cellular localization | 100.0% (2/2) | 4.08 | 0.003488 | 0.004536 |
| GO:0031324 | negative regulation of cellular metabolic process | 100.0% (2/2) | 4.07 | 0.003549 | 0.0046 |
| GO:0043565 | sequence-specific DNA binding | 100.0% (2/2) | 4.06 | 0.003616 | 0.004672 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 100.0% (2/2) | 4.05 | 0.003662 | 0.004717 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 100.0% (2/2) | 4.0 | 0.003911 | 0.005022 |
| GO:0032555 | purine ribonucleotide binding | 100.0% (2/2) | 3.98 | 0.004024 | 0.005134 |
| GO:0022607 | cellular component assembly | 100.0% (2/2) | 3.98 | 0.004017 | 0.005142 |
| GO:0009891 | positive regulation of biosynthetic process | 100.0% (2/2) | 3.97 | 0.00405 | 0.005151 |
| GO:0017076 | purine nucleotide binding | 100.0% (2/2) | 3.97 | 0.004076 | 0.005168 |
| GO:0003723 | RNA binding | 100.0% (2/2) | 3.94 | 0.004221 | 0.005319 |
| GO:0048584 | positive regulation of response to stimulus | 100.0% (2/2) | 3.94 | 0.004214 | 0.005327 |
| GO:0032553 | ribonucleotide binding | 100.0% (2/2) | 3.94 | 0.004251 | 0.00534 |
| GO:0097367 | carbohydrate derivative binding | 100.0% (2/2) | 3.86 | 0.004756 | 0.005955 |
| GO:0009966 | regulation of signal transduction | 100.0% (2/2) | 3.79 | 0.005225 | 0.006524 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 100.0% (2/2) | 3.78 | 0.005292 | 0.006587 |
| GO:0070887 | cellular response to chemical stimulus | 100.0% (2/2) | 3.73 | 0.005652 | 0.007013 |
| GO:0023051 | regulation of signaling | 100.0% (2/2) | 3.68 | 0.006055 | 0.007468 |
| GO:0006996 | organelle organization | 100.0% (2/2) | 3.68 | 0.006079 | 0.007474 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 100.0% (2/2) | 3.68 | 0.006051 | 0.007485 |
| GO:0010646 | regulation of cell communication | 100.0% (2/2) | 3.67 | 0.006143 | 0.00753 |
| GO:0080134 | regulation of response to stress | 100.0% (2/2) | 3.65 | 0.006316 | 0.00772 |
| GO:0051239 | regulation of multicellular organismal process | 100.0% (2/2) | 3.64 | 0.006451 | 0.007861 |
| GO:0009892 | negative regulation of metabolic process | 100.0% (2/2) | 3.63 | 0.006492 | 0.007888 |
| GO:0031325 | positive regulation of cellular metabolic process | 100.0% (2/2) | 3.59 | 0.006856 | 0.008305 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 100.0% (2/2) | 3.58 | 0.007009 | 0.008465 |
| GO:0003677 | DNA binding | 100.0% (2/2) | 3.57 | 0.00713 | 0.008585 |
| GO:0043168 | anion binding | 100.0% (2/2) | 3.56 | 0.007152 | 0.008586 |
| GO:0043228 | non-membrane-bounded organelle | 100.0% (2/2) | 3.5 | 0.007797 | 0.009306 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 100.0% (2/2) | 3.5 | 0.007797 | 0.009306 |
| GO:0006355 | regulation of DNA-templated transcription | 100.0% (2/2) | 3.47 | 0.008098 | 0.009637 |
| GO:2001141 | regulation of RNA biosynthetic process | 100.0% (2/2) | 3.47 | 0.008154 | 0.009647 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 100.0% (2/2) | 3.47 | 0.008144 | 0.009664 |
| GO:0009893 | positive regulation of metabolic process | 100.0% (2/2) | 3.37 | 0.00929 | 0.01096 |
| GO:0010035 | response to inorganic substance | 100.0% (2/2) | 3.35 | 0.009659 | 0.011362 |
| GO:0051252 | regulation of RNA metabolic process | 100.0% (2/2) | 3.34 | 0.009805 | 0.011501 |
| GO:0000166 | nucleotide binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.012021 |
| GO:1901265 | nucleoside phosphate binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.012021 |
| GO:0016787 | hydrolase activity | 100.0% (2/2) | 3.29 | 0.010496 | 0.012205 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 100.0% (2/2) | 3.23 | 0.011368 | 0.013181 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.22 | 0.011593 | 0.013404 |
| GO:0046872 | metal ion binding | 100.0% (2/2) | 3.21 | 0.011675 | 0.013461 |
| GO:0050793 | regulation of developmental process | 100.0% (2/2) | 3.18 | 0.012229 | 0.01402 |
| GO:0043169 | cation binding | 100.0% (2/2) | 3.18 | 0.012223 | 0.014053 |
| GO:0036094 | small molecule binding | 100.0% (2/2) | 3.16 | 0.012571 | 0.014332 |
| GO:0048523 | negative regulation of cellular process | 100.0% (2/2) | 3.16 | 0.012542 | 0.014339 |
| GO:0065008 | regulation of biological quality | 100.0% (2/2) | 3.11 | 0.013322 | 0.015145 |
| GO:0032991 | protein-containing complex | 100.0% (2/2) | 3.02 | 0.015279 | 0.017322 |
| GO:0031326 | regulation of cellular biosynthetic process | 100.0% (2/2) | 3.01 | 0.015348 | 0.017352 |
| GO:0010468 | regulation of gene expression | 100.0% (2/2) | 2.96 | 0.016399 | 0.018438 |
| GO:0009889 | regulation of biosynthetic process | 100.0% (2/2) | 2.97 | 0.016366 | 0.018452 |
| GO:0051179 | localization | 100.0% (2/2) | 2.9 | 0.017845 | 0.020008 |
| GO:0048583 | regulation of response to stimulus | 100.0% (2/2) | 2.88 | 0.018347 | 0.020515 |
| GO:0048522 | positive regulation of cellular process | 100.0% (2/2) | 2.85 | 0.019139 | 0.021341 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (2/2) | 2.78 | 0.02118 | 0.023488 |
| GO:0003676 | nucleic acid binding | 100.0% (2/2) | 2.78 | 0.021157 | 0.023527 |
| GO:0051716 | cellular response to stimulus | 100.0% (2/2) | 2.76 | 0.021689 | 0.023988 |
| GO:0051707 | response to other organism | 100.0% (2/2) | 2.74 | 0.02238 | 0.024685 |
| GO:0048519 | negative regulation of biological process | 100.0% (2/2) | 2.7 | 0.023543 | 0.025897 |
| GO:0044419 | biological process involved in interspecies interaction between organisms | 100.0% (2/2) | 2.7 | 0.023693 | 0.025992 |
| GO:0080090 | regulation of primary metabolic process | 100.0% (2/2) | 2.69 | 0.024112 | 0.02638 |
| GO:0060255 | regulation of macromolecule metabolic process | 100.0% (2/2) | 2.66 | 0.024978 | 0.027254 |
| GO:0043207 | response to external biotic stimulus | 100.0% (2/2) | 2.64 | 0.025686 | 0.027952 |
| GO:0016043 | cellular component organization | 100.0% (2/2) | 2.61 | 0.026671 | 0.028717 |
| GO:1901700 | response to oxygen-containing compound | 100.0% (2/2) | 2.61 | 0.026671 | 0.028717 |
| GO:0031323 | regulation of cellular metabolic process | 100.0% (2/2) | 2.62 | 0.026604 | 0.028798 |
| GO:0009607 | response to biotic stimulus | 100.0% (2/2) | 2.62 | 0.026563 | 0.028829 |
| GO:0048518 | positive regulation of biological process | 100.0% (2/2) | 2.53 | 0.029835 | 0.032039 |
| GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 2.52 | 0.030234 | 0.032382 |
| GO:0022414 | reproductive process | 100.0% (2/2) | 2.51 | 0.030977 | 0.033091 |
| GO:0032501 | multicellular organismal process | 100.0% (2/2) | 2.47 | 0.032398 | 0.034518 |
| GO:0043167 | ion binding | 100.0% (2/2) | 2.46 | 0.032934 | 0.034998 |
| GO:0010033 | response to organic substance | 100.0% (2/2) | 2.46 | 0.033055 | 0.035035 |
| GO:0019222 | regulation of metabolic process | 100.0% (2/2) | 2.38 | 0.036999 | 0.039113 |
| GO:0048856 | anatomical structure development | 100.0% (2/2) | 2.33 | 0.039796 | 0.041852 |
| GO:0009605 | response to external stimulus | 100.0% (2/2) | 2.33 | 0.039704 | 0.041864 |